Cardiac progenitor cells (CPCs) have rapidly advanced to clinical trials, yet little is known regarding their interaction with the microenvironment. Signaling cues present in the microenvironment change with development and disease. This work aims to assess the influence of two distinct signaling moieties on CPCs: cyclic biaxial strain and extracellular matrix. We evaluate four endpoints for improving CPC therapy: paracrine signaling, proliferation, connexin43 expression, and alignment. Vascular endothelial growth factor A (about 900 pg/mL) was secreted by CPCs cultured on fibronectin and collagen I. The application of mechanical strain increased vascular endothelial growth factor A secretion 2-4-fold for CPCs cultured on poly-L-lysine, lam...
Human epicardium-derived cells (hEPDCs) transplanted in the NOD-SCID mouse heart after myocardial in...
We examined the effects of the microenvironment on vascular differentiation of murine cardiovascular...
Angiogenic cell therapy is currently being developed as a treatment for coronary artery disease (CAD...
Cardiac progenitor cells (CPCs) have rapidly advanced to clinical trials, yet little is known regard...
Heart failure, predominately caused by myocardial infarction (MI), is the leading cause of death in ...
Rationale: Adoptive transfer of cardiac progenitor cells (CPCs) has entered clinical application, de...
Stem or progenitor cell populations are often established in unique niche microenvironments that reg...
In cardiac fibrosis, in response to stress or injury, cardiac fibroblasts deposit excessive amounts ...
Cardiomyocytes in the body are subjected to cyclic mechanical strain induced by the rhythmic heart b...
The use of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) has great potential for ...
Heart failure is one of the leading causes of morbidity and mortality in the United States today. Me...
Conference Theme: An Unveiling of Stem Cell InnovationPluripotent stem cell-derived cardiac progenit...
Components of the cardiac extracellular matrix (ECM) are synthesized by residing cells and are conti...
Cardiac adverse remodeling is characterized by biological changes that affect the composition and ar...
Cardiomyocytes (CMs) differentiated from human embryonic stem cells (hESCs) are a promising and pote...
Human epicardium-derived cells (hEPDCs) transplanted in the NOD-SCID mouse heart after myocardial in...
We examined the effects of the microenvironment on vascular differentiation of murine cardiovascular...
Angiogenic cell therapy is currently being developed as a treatment for coronary artery disease (CAD...
Cardiac progenitor cells (CPCs) have rapidly advanced to clinical trials, yet little is known regard...
Heart failure, predominately caused by myocardial infarction (MI), is the leading cause of death in ...
Rationale: Adoptive transfer of cardiac progenitor cells (CPCs) has entered clinical application, de...
Stem or progenitor cell populations are often established in unique niche microenvironments that reg...
In cardiac fibrosis, in response to stress or injury, cardiac fibroblasts deposit excessive amounts ...
Cardiomyocytes in the body are subjected to cyclic mechanical strain induced by the rhythmic heart b...
The use of induced pluripotent stem cell (iPSC)-derived cardiomyocytes (CM) has great potential for ...
Heart failure is one of the leading causes of morbidity and mortality in the United States today. Me...
Conference Theme: An Unveiling of Stem Cell InnovationPluripotent stem cell-derived cardiac progenit...
Components of the cardiac extracellular matrix (ECM) are synthesized by residing cells and are conti...
Cardiac adverse remodeling is characterized by biological changes that affect the composition and ar...
Cardiomyocytes (CMs) differentiated from human embryonic stem cells (hESCs) are a promising and pote...
Human epicardium-derived cells (hEPDCs) transplanted in the NOD-SCID mouse heart after myocardial in...
We examined the effects of the microenvironment on vascular differentiation of murine cardiovascular...
Angiogenic cell therapy is currently being developed as a treatment for coronary artery disease (CAD...